Navigation Links
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Date:1/3/2008

Novel non-estrogen oral therapy in development for menopausal symptoms

ANN ARBOR, Mich., Jan. 3 /PRNewswire/ -- QuatRx Pharmaceuticals Company today announced positive results from a pivotal Phase 3 study of Ophena(TM) (ospemifene) to treat postmenopausal women with vulvovaginal atrophy, a common condition associated with menopause. Top line data show that the multi-center, double-blind, placebo-controlled study successfully met all of its co-primary endpoints. The study was conducted in 80 U.S. centers and involved more than 800 women. Full results of the study are being submitted to an upcoming scientific meeting for release later in 2008.

Ophena(TM) is a novel selective estrogen receptor modulator (SERM) that is being studied as a treatment for women with postmenopausal vaginal syndrome (PVS), also known as vaginal atrophy. PVS is a common condition in postmenopausal women characterized by symptoms such as vaginal dryness, irritation and pain associated with sexual intercourse. The only currently FDA approved products for this condition all contain the hormone estrogen. However, many women and their physicians avoid using estrogen-containing products due to concerns about the risks of such therapy identified in the Women's Health Initiative (WHI) and other studies.

"These results are very exciting and we believe demonstrate that Ophena(TM) has the potential to bring clear clinical benefit to women affected by PVS, many of whom have had only estrogen therapy as a treatment option for their condition to date," said Robert L. Zerbe, M.D., chief executive officer and president of QuatRx. "We believe Ophena(TM) could provide the first non- estrogen prescription treatment alternative for this condition. QuatRx is well positioned to continue with our plans to advance this exciting product to commercialization, pending regulatory review and approval."

This pivotal Phase 3 study was designed to evaluate the efficacy of Ophena(TM) versus p
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... , April 20, 2015  Purdue Pharma, ... Alan Butcher has joined the company ... Development. Alan will have responsibility for all of ... and development-stage products that would benefit from our ... a proven leader," said Purdue President & CEO ...
(Date:4/20/2015)... pharmacy cost increases for active employees and pre- and post-65 ... 2016, according to an analysis by Aon Hewitt , ... Aon plc (NYSE: AON ). Pharmacy cost increases ... in 2015 and will continue to rise to 10 percent ... of increase in 2017, with pharmacy costs rising by 10.5 ...
(Date:4/20/2015)... , April 20, 2015 ... organization that focuses on high-tech, high-touch service delivery, ... behavioral health services during the National Council for ... which takes place April 20–22, 2015, at the ... Orlando, Fla. , attracts participants from ...
Breaking Medicine Technology:Purdue Pharma Names J. Alan Butcher Senior Vice President of Licensing & Business Development 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3
(Date:4/21/2015)... Atlantic Information Services, Inc. (AIS) ... Dual Eligibles Database, a brand-new, continually updated online ... the more than 9 million Medicare-Medicaid dual eligibles ... $300 billion in annual health care spending. Developed ... that also creates the industry-leading AIS’s Directory of ...
(Date:4/21/2015)... With a growing number of Americans ... indicates that international political instability and terrorism top the ... by Clements, a global insurance provider with 68 years’ ... country of citizenship, also found strong concern but lack ... care insurance overseas . , Asked to choose the ...
(Date:4/21/2015)... Angeles, CA (PRWEB) April 21, 2015 ... power score of 3.8 out of 5, indicating generally ... due to its low barriers to entry and the ... are only moved relatively short distances,” says IBISWorld research ... scattered throughout the country, typically serving local and regional ...
(Date:4/21/2015)... In early April, Autism Awareness Month, monuments and ... to a growing global crisis. One area that could ... educational needs of individuals on the spectrum. , ... each autistic person is unique and distinctive, there is ... and emotional needs of individuals on the spectrum are ...
(Date:4/21/2015)... 2015 On May 12, 2015, ... of its Center for Graduate Studies, located near ... The campus recently completed a stunning renovation, but ... that has administrators and students abuzz. , ... Master of Science in Nursing, Post-Master’s Family Nurse ...
Breaking Medicine News(10 mins):Health News:New AIS Database Tracks All Programs, Plans Serving the Dual-Eligible Community 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 2Health News:Potential Expatriate Retirees Fear Political Violence, International Health Insurance Coverage 3Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Bulk Food-Grade Transportation Services Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 2Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 3Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 4Health News:West Coast University Opens a Center for Graduate Studies 2Health News:West Coast University Opens a Center for Graduate Studies 3
... THURSDAY, Sept. 29 (HealthDay News) --,New genes associated with ... analysis of genetic data related to the disease. ... large databases for DNA data from about 10,000 people ... In addition to validating results from previous research, the ...
... Sept. 29 (HealthDay News) -- Brain development doesn,t stop in ... a new study says. The finding challenges a long-held ... For their study, the University of Alberta researchers used ... 5 to 32. Each volunteer was scanned at least twice. ...
... editor of the Journal of the American Chemical Society ... Ph.D. and Rakesh Agrawal, Ph.D., are among 12 eminent ... nation,s highest honors in science and innovation. "Each ... a passion for innovation, fearlessness even as they explore the ...
... , THURSDAY, Sept. 29 (HealthDay News) -- Campus-wide smoking ... nicotine habit, new research suggests. The finding stems from ... with a ban and one without. "Although we haven,t ... the most to the positive changes in students, smoking rates, ...
... which are widely deemed as a nuisance plant, are vital ... new University of Hull study published in the journal ... and seed, they are an integral part of our ecosystem ... farms, they provide food for over 330 species of insects, ...
... A loss of a sense of smell can be one ... suggests that an abnormal form of a protein -- amyloid ... with the Alzheimer,s disease may be to blame. A ... high levels of the abnormal protein experienced high levels of ...
Cached Medicine News:Health News:White House honors editor of American Chemical Society journal and 2 ACS members 2Health News:Campus Smoking Bans May Help College Students Quit 2Health News:Weeds are vital to the existence of farmland species, study finds 2Health News:Abnormal Protein May Explain Loss of Smell With Alzheimer's 2
... The SG210D combines a slab gel dryer ... convenient gel drying without any hardware setup. The ... fixed in acetic acid, protein/agarose gels, and multiple ... in 60 minutes or less. , Completely ...
Inquire...
... system, Hoefers Easy Breeze can dry as many as ... Mini-Gels (8 x 10 cm) at a time. , ... drying oven, a specially designed loading platform, and two ... no awkward connections., The Gel Frame is largely responsible ...
... HydroTech™ gel drying system, 220-240 V, includes Model ... The Model 583 gel dryer is a vacuum-based ... x 45 cm with variable temperature control and ... a water-based vacuum pump used for pulling vacuum ...
Medicine Products: